INFANRIX 25 ug/.5mL
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed · SUSPENSION · GlaxoSmithKline Biologicals SA
INFANRIX is a suspension containing diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed at 25 ug/.5mL, taken intramuscular. Manufactured by GlaxoSmithKline Biologicals SA.
Key Facts
- Brand Name
- INFANRIX
- Generic Name
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed
- NDC Code (Product)
58160-810- Manufacturer
- GlaxoSmithKline Biologicals SA
- Strength
- 25 ug/.5mL
- Dosage Form
- SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA103647
- Marketing Start
- 07/24/2009
Recall History
No Recall HistoryFrequently Asked Questions
What is INFANRIX used for?
INFANRIX contains Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed. It is a suspension taken intramuscular. Consult your doctor for specific uses.
Is INFANRIX a controlled substance?
INFANRIX is not classified as a controlled substance by the DEA.
What is the generic name for INFANRIX?
The generic name for INFANRIX is Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed. There are no other listed brand versions of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed.
What is the NDC code for INFANRIX 25 ug/.5mL?
The NDC (National Drug Code) for INFANRIX 25 ug/.5mL is 58160-810, listed by GlaxoSmithKline Biologicals SA.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)